CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-16 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −3,177 | $19.32 | $61K | 63,414 |
| 2017-08-16 | Hora Maninder SVP Pharma Dev & Mfg Ops | Sale | −2,956 | $19.32 | $57K | 58,233 |
| 2017-08-16 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −1,997 | $19.32 | $39K | 41,575 |
| 2017-08-16 | Doberstein Stephen K SVP & Chief Scientific Officer | Sale | −1,701 | $19.32 | $33K | 31,102 |
| 2017-08-10 | WHITFIELD ROY A Director | Purchase | +35,000 | $17.95 | $628K | 133,000 |
| 2017-07-18 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion | +54,920 | $11.04 | $606K | 98,492 |
| 2017-07-18 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −54,920 | $21.10 | $1.2M | 43,572 |
| 2017-07-18 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion · Stock Option | −54,920 | 413,752 | ||
| 2017-07-14 | Lingnau Lutz Director | Exercise or conversion | +30,000 | $14.26 | $428K | 53,450 |
| 2017-07-14 | Lingnau Lutz Director | Sale | −30,000 | $20.76 | $623K | 23,450 |
| 2017-07-14 | Lingnau Lutz Director | Exercise or conversion · Stock Option | −30,000 | 0 | ||
| 2017-07-12 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion | +36,691 | $11.04 | $405K | 80,263 |
| 2017-07-12 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −36,691 | $21.09 | $774K | 43,572 |
| 2017-07-12 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion · Stock Option | −36,691 | 468,672 | ||
| 2017-07-11 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion | +8,389 | $11.04 | $93K | 51,961 |
| 2017-07-11 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −8,389 | $21.04 | $177K | 43,572 |
| 2017-07-11 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion · Stock Option | −8,389 | 505,363 | ||
| 2017-06-26 | Krivulka Joseph J Director | Exercise or conversion | +15,000 | $8.37 | $126K | 73,000 |
| 2017-06-26 | Krivulka Joseph J Director | Exercise or conversion · Stock Option | −15,000 | 0 | ||
| 2017-06-07 | Nicholson John SVP & Chief Operating Officer | Exercise or conversion | +150,000 | $6.34 | $951K | 328,943 |
Page 42 of 43 · 847 trades